1 |
Haleblian, J. K., Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci., 64, 1269-1288 (1975)
DOI
|
2 |
Sohn, Y. T., Effect of crystal form on bioavailability. J. Kor. Pharm. Sci., 34, 443-452 (2004)
과학기술학회마을
|
3 |
Sohn, Y. T., Rhee, J. K., and Im, W. B., Polymorphism of Clarithromycin. Arch. Pharm. Res., 23, 381-384 (2000)
DOI
ScienceOn
|
4 |
Higuchi, W.I., Lau, P. K., Higuchi, T., and Shell, J. W., Polymorphism and drug availability, solubility relations in the methylprednisolone system. J. Pharm. Sci., 52, 150-153 (1963)
DOI
|
5 |
Grunenberg, A., Polymorphie und thermische analyse pharmazeutischer Wirkstoffe. Pharmazie in unserer Zeit, 26, 224- 231 (1997)
DOI
ScienceOn
|
6 |
Kuhnert-Brandstatter, M., Polymorphie von Arzneistoffen und ihre Bedeutung in der pharmazeutischen Technologie. Informationsdienst A.P.V., 19, 73-90 (1973)
|
7 |
Huttenrauch, R., Fundamentals of Pharmaceutics. Acta Pharm. Technol., 34, 1-10 (1988)
|
8 |
Kuhnert-Brandstätter, M. and Lehner, G., Differentialthermoanalyse und IR-spektroskopische untersucungen von arzneistoffen, die als hydrate vorliegen. Sci. Pharm., 52, 267- 279 (1984)
|
9 |
Shefter, E. and Higuchi, T., Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm. Sci., 52, 781-791 (1963)
DOI
|
10 |
Haleblian, J. K. and McCrone, W. C., Pharmaceutical applications of polymorphism. J. Pharm. Sci., 58, 911-929 (1969)
DOI
|
11 |
Giron, D., Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates. Thermochim. Acta, 248, 1-59 (1995)
DOI
ScienceOn
|